Author:
Rano Thomas A,Cheng Yuan,Huening Tracy T,Zhang Fengqi,Schleif William A,Gabryelski Lori,Olsen David B,Kuo Lawrence C,Lin Jiunn H,Xu Xin,Olah Timothy V,McLoughlin Debra A,King Richard,Chapman Kevin T,Tata James R
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference16 articles.
1. Clinically effective HIV-1 protease inhibitors
2. Editorial
3. The hepatic/intestinal metabolism and pharmacokinetics of indinavir has been extensively investigated: (a) Lin, J. H. Adv. Drug Del. Rev. 1999, 39, 211. (b) Chiba, M.; Hensleigh, M.; Lin, J. H. Biochem. Pharmacol. 1997, 53, 1187. (c) Lin, J. H.; Chiba, C.; Balani, S. K.; Chen, I.-W.; Kwei, G. Y.-S.; Vastag, K. J.; Nishime, J. A. Drug Metab. Dispos. 1996, 24, 1111.
4. The solid-phase synthesis of HIV protease inhibitors has been previously reported: (a) Baker, C. T.; Salituro, F. G.; Court, J. J.; Deininger, D. D.; Kim, E. E.; Li, B.; Novak, P. M.; Rao, B. G.; Pazhanisamy, S.; Schairer, W. C.; Tung, R. D. Bioorg. Med. Chem. Lett. 1998, 8, 3631. (b) Wang, G. T.; Li, S.; Wideburg, N.; Krafft, G. A.; Kempf, J. D. J. Med. Chem 1995, 38, 2995. (c) Kick, E. D.; Ellman, J. A. J. Med. Chem. 1995, 38, 1427 and references sited therein.
5. L-735,524: The Design of a Potent and Orally Bioavailable HIV Protease Inhibitor
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献